02/29/2012
Matti Niemela, MD, PhD; Kari Kervinen, MD, PhD; Mikko Pietila, MD, PhD; Jussi Sia, MD; Kai Nyman, MD; Wail Nammas, MD, PhD; Antti Ylitalo, MD, PhD; Pasi P. Karjalainen, MD, PhD; Juhani K.E. Airaksinen, MD, PhD, FESC; Petri O. Tuomainen, MD, PhD
Abstract: Background. The TITAX-AMI trial demonstrated a better clinical outcome of titanium-nitride-oxide-coated bioactive stents (BAS) as compared with paclitaxel-eluting stents (PES) in patients with acute myocardial infarction (MI)...
Abstract: Background. The TITAX-AMI trial demonstrated a better clinical outcome of titanium-nitride-oxide-coated bioactive stents (BAS) as compared with paclitaxel-eluting stents (PES) in patients with acute myocardial infarction (MI)...
Abstract: Background. The...